{"id":2734,"date":"2024-09-05T15:21:00","date_gmt":"2024-09-05T13:21:00","guid":{"rendered":"https:\/\/prueba.esclerosismultiplegalicia.org\/?p=2734"},"modified":"2025-09-05T16:09:22","modified_gmt":"2025-09-05T14:09:22","slug":"novo-farmaco-para-a-esclerose-multiple-poderia-revertir-o-dano-neuroloxico","status":"publish","type":"post","link":"http:\/\/esclerosismultiplegalicia.org\/index.php\/2024\/09\/05\/novo-farmaco-para-a-esclerose-multiple-poderia-revertir-o-dano-neuroloxico\/","title":{"rendered":"Novo f\u00e1rmaco para a Esclerose M\u00faltiple poder\u00eda revertir o dano neurol\u00f3xico"},"content":{"rendered":"\n<h3 class=\"wp-block-heading has-theme-palette-2-color has-text-color has-link-color wp-elements-980291480ec2b73ac4eb670efda1ae1a\"><em>Novo tratamento poder\u00eda revertir o dano neurol\u00f3xico na EM, abrindo unha nova esperanza para mill\u00f3ns de persoas.<\/em><\/h3>\n\n\n\n<p>Un equipo de cient\u00edficos da&nbsp;<strong><a href=\"https:\/\/www.universityofcalifornia.edu\/\" target=\"_blank\" rel=\"noreferrer noopener\">Universidade de California<\/a><\/strong>&nbsp;en San Francisco e a empresa&nbsp;<strong><a href=\"https:\/\/www.contineum-tx.com\/\" target=\"_blank\" rel=\"noreferrer noopener\">Contineum Therapeutics<\/a><\/strong>&nbsp;desenvolveron un&nbsp;<strong>f\u00e1rmaco&nbsp;innovador<\/strong>&nbsp;que poder\u00eda cambiar o tratamento da&nbsp;<a href=\"https:\/\/esclerosismultiplegalicia.org\/esclerosis_multiple_es.html\" target=\"_blank\" rel=\"noreferrer noopener\">Esclerose M\u00faltiple<\/a>&nbsp;(EM). Este medicamento, co\u00f1ecido como&nbsp;<strong>PIPE-307<\/strong>, demostrou en estudos a s\u00faa capacidade para&nbsp;<strong>rexenerar a mielina<\/strong>, a capa protectora das c\u00e9lulas nerviosas que se dana na EM.<\/p>\n\n\n\n<p>A mielina act\u00faa como illante dos nervios, permitindo que os impulsos el\u00e9ctricos viaxen eficientemente. A EM destr\u00fae esta capa, deixando aos ax\u00f3ns nerviosos expostos e causando unha ampla variedade de&nbsp;<a href=\"https:\/\/esclerosismultiplegalicia.org\/como_se_puede_manifestar_la_esclerosis_multiple_es.html\" target=\"_blank\" rel=\"noreferrer noopener\"><strong>problemas neurol\u00f3xicos<\/strong><\/a>, como dificultade para moverse, perda de visi\u00f3n, e en casos severos, par\u00e1lise, entre outros. A nova terapia enf\u00f3case en&nbsp;<strong>estimular a produci\u00f3n de oligodendrocitos<\/strong>, c\u00e9lulas especializadas na creaci\u00f3n de mielina, o que abre unha porta \u00e1 posibilidade de revertir o dano causado pola enfermidade.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Como funciona PIPE-307?<\/h3>\n\n\n\n<p>O f\u00e1rmaco PIPE-307 act\u00faa&nbsp;<strong>bloqueando un receptor espec\u00edfico<\/strong>&nbsp;chamado M1R, localizado nas c\u00e9lulas precursoras de oligodendrocitos (OPC), as responsables de reparar o dano neurol\u00f3xico. Segundo o doutor&nbsp;<strong>Jonah Chan<\/strong>, quen lidera o proxecto, este \u00e9 o primeiro medicamento dese\u00f1ado especificamente para activar a&nbsp;<strong>remielinizaci\u00f3n<\/strong>&nbsp;dos nervios. A\u00ednda que estudos previos con outros medicamentos, como a clemastina, demostraron certa capacidade de rexeneraci\u00f3n, PIPE-307 mostra unha efectividade moito maior.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Investigaci\u00f3n e desenvolvemento<\/h3>\n\n\n\n<p>O descubrimento deste tratamento \u00e9 froito dunha d\u00e9cada de investigaci\u00f3n. En 2014, Chan e o seu equipo descubriron que un f\u00e1rmaco antihistam\u00ednico ti\u00f1a a capacidade de estimular a remielinizaci\u00f3n, pero non era o suficientemente espec\u00edfico. A partires dese achado, os investigadores dirixiron os seus esforzos cara o desenvolvemento dun medicamento m\u00e1is preciso que actuara directamente sobre o receptor M1R.<\/p>\n\n\n\n<p>En colaboraci\u00f3n con Contineum Therapeutics, os cient\u00edficos lograron dese\u00f1ar PIPE-307,&nbsp;<strong>un medicamento capaz de bloquear este receptor e activar as OPC<\/strong>&nbsp;para rexenerar a mielina nas \u00e1reas danadas do Sistema Nervioso Central (SNC). Actualmente, PIPE-307 est\u00e1 en&nbsp;<strong>ensaios cl\u00ednicos de fase II<\/strong>&nbsp;en persoas con EM, tras superar con \u00e9xito os estudos iniciais que demostraron a s\u00faa seguridade en humanos.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Un futuro prometedor<\/h3>\n\n\n\n<p>Se PIPE-307 supera os ensaios cl\u00ednicos, poder\u00eda&nbsp;<strong>revolucionar o tratamento da EM<\/strong>, ofrecendo unha nova esperanza a mill\u00f3ns de persoas que viven con ela. O avance&nbsp;<strong>deter\u00eda a progresi\u00f3n<\/strong>&nbsp;da enfermidade e&nbsp;<strong>poder\u00eda revertir os danos<\/strong>&nbsp;xa sufridos, algo que ata agora non era posible.<\/p>\n\n\n\n<p>O doutor&nbsp;<strong>Ari Green<\/strong>, coautor do estudo, destaca a importancia deste descubrimento: &#8220;Poderiamos ter a oportunidade non s\u00f3 de deter a enfermidade, sen\u00f3n tam\u00e9n de curala&#8221;. Esta nova clase de medicamentos baseados na remielinizaci\u00f3n representa un avance importante na busca dunha cura para a EM.<\/p>\n\n\n\n<p><strong>Podes ler o artigo completo&nbsp;<a href=\"https:\/\/www.20minutos.es\/noticia\/5555683\/0\/desarrollan-un-farmaco-que-podria-revertir-dano-causado-por-esclerosis-multiple\/?fbclid=IwY2xjawFCc95leHRuA2FlbQIxMQABHUCG8PYtZIRU-h-_dpnEbXkh0_1e90XjIOwRczH4_FCtzLDoRr0Ci8yGuA_aem_YOjc4O_xSDItcEsRUIaLJw\" target=\"_blank\" rel=\"noreferrer noopener\">aqu\u00ed<\/a>.&nbsp;<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Novo tratamento poder\u00eda revertir o dano neurol\u00f3xico na EM, abrindo&hellip; <a class=\"continue\" href=\"http:\/\/esclerosismultiplegalicia.org\/index.php\/2024\/09\/05\/novo-farmaco-para-a-esclerose-multiple-poderia-revertir-o-dano-neuroloxico\/\">Ler m\u00e1is sobre<span> Novo f\u00e1rmaco para a Esclerose M\u00faltiple poder\u00eda revertir o dano neurol\u00f3xico<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_kad_post_transparent":"","_kad_post_title":"","_kad_post_layout":"","_kad_post_sidebar_id":"","_kad_post_content_style":"","_kad_post_vertical_padding":"","_kad_post_feature":"","_kad_post_feature_position":"","_kad_post_header":false,"_kad_post_footer":false,"footnotes":""},"categories":[103],"tags":[102,101],"class_list":["post-2734","post","type-post","status-publish","format-standard","hentry","category-novas","tag-investigacion","tag-tratamentos"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.1.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Novo f\u00e1rmaco para a Esclerose M\u00faltiple poder\u00eda revertir o dano neurol\u00f3xico - FEGADEM<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/esclerosismultiplegalicia.org\/index.php\/2024\/09\/05\/novo-farmaco-para-a-esclerose-multiple-poderia-revertir-o-dano-neuroloxico\/\" \/>\n<meta property=\"og:locale\" content=\"gl_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Novo f\u00e1rmaco para a Esclerose M\u00faltiple poder\u00eda revertir o dano neurol\u00f3xico - FEGADEM\" \/>\n<meta property=\"og:description\" content=\"Novo tratamento poder\u00eda revertir o dano neurol\u00f3xico na EM, abrindo&hellip; Ler m\u00e1is sobre Novo f\u00e1rmaco para a Esclerose M\u00faltiple poder\u00eda revertir o dano neurol\u00f3xico\" \/>\n<meta property=\"og:url\" content=\"https:\/\/esclerosismultiplegalicia.org\/index.php\/2024\/09\/05\/novo-farmaco-para-a-esclerose-multiple-poderia-revertir-o-dano-neuroloxico\/\" \/>\n<meta property=\"og:site_name\" content=\"FEGADEM\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/esclerosemultiplegal?locale=es_ES\" \/>\n<meta property=\"article:published_time\" content=\"2024-09-05T13:21:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-09-05T14:09:22+00:00\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@fegadem\" \/>\n<meta name=\"twitter:site\" content=\"@fegadem\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/esclerosismultiplegalicia.org\/index.php\/2024\/09\/05\/novo-farmaco-para-a-esclerose-multiple-poderia-revertir-o-dano-neuroloxico\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/esclerosismultiplegalicia.org\/index.php\/2024\/09\/05\/novo-farmaco-para-a-esclerose-multiple-poderia-revertir-o-dano-neuroloxico\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/esclerosismultiplegalicia.org\/#\/schema\/person\/6c5800f07aa0462086b750a2df88cfb4\"},\"headline\":\"Novo f\u00e1rmaco para a Esclerose M\u00faltiple poder\u00eda revertir o dano neurol\u00f3xico\",\"datePublished\":\"2024-09-05T13:21:00+00:00\",\"dateModified\":\"2025-09-05T14:09:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/esclerosismultiplegalicia.org\/index.php\/2024\/09\/05\/novo-farmaco-para-a-esclerose-multiple-poderia-revertir-o-dano-neuroloxico\/\"},\"wordCount\":535,\"publisher\":{\"@id\":\"https:\/\/esclerosismultiplegalicia.org\/#organization\"},\"keywords\":[\"Investigaci\u00f3n\",\"Tratamentos\"],\"articleSection\":[\"Novas\"],\"inLanguage\":\"gl-ES\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/esclerosismultiplegalicia.org\/index.php\/2024\/09\/05\/novo-farmaco-para-a-esclerose-multiple-poderia-revertir-o-dano-neuroloxico\/\",\"url\":\"https:\/\/esclerosismultiplegalicia.org\/index.php\/2024\/09\/05\/novo-farmaco-para-a-esclerose-multiple-poderia-revertir-o-dano-neuroloxico\/\",\"name\":\"Novo f\u00e1rmaco para a Esclerose M\u00faltiple poder\u00eda revertir o dano neurol\u00f3xico - FEGADEM\",\"isPartOf\":{\"@id\":\"https:\/\/esclerosismultiplegalicia.org\/#website\"},\"datePublished\":\"2024-09-05T13:21:00+00:00\",\"dateModified\":\"2025-09-05T14:09:22+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/esclerosismultiplegalicia.org\/index.php\/2024\/09\/05\/novo-farmaco-para-a-esclerose-multiple-poderia-revertir-o-dano-neuroloxico\/#breadcrumb\"},\"inLanguage\":\"gl-ES\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/esclerosismultiplegalicia.org\/index.php\/2024\/09\/05\/novo-farmaco-para-a-esclerose-multiple-poderia-revertir-o-dano-neuroloxico\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/esclerosismultiplegalicia.org\/index.php\/2024\/09\/05\/novo-farmaco-para-a-esclerose-multiple-poderia-revertir-o-dano-neuroloxico\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inicio\",\"item\":\"http:\/\/esclerosismultiplegalicia.org\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Novo f\u00e1rmaco para a Esclerose M\u00faltiple poder\u00eda revertir o dano neurol\u00f3xico\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/esclerosismultiplegalicia.org\/#website\",\"url\":\"https:\/\/esclerosismultiplegalicia.org\/\",\"name\":\"FEGADEM\",\"description\":\"Traballamos mellorando a calidade de vida das persoas con Esclerose M\u00faltiple en Galicia.\",\"publisher\":{\"@id\":\"https:\/\/esclerosismultiplegalicia.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/esclerosismultiplegalicia.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"gl-ES\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/esclerosismultiplegalicia.org\/#organization\",\"name\":\"FEGADEM (Federaci\u00f3n Galega de Esclerose M\u00faltiple)\",\"url\":\"https:\/\/esclerosismultiplegalicia.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"gl-ES\",\"@id\":\"https:\/\/esclerosismultiplegalicia.org\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/esclerosismultiplegalicia.org\/wp-content\/uploads\/2025\/05\/cropped-FEGADEM_Imagotipo-scaled-1.png\",\"contentUrl\":\"http:\/\/esclerosismultiplegalicia.org\/wp-content\/uploads\/2025\/05\/cropped-FEGADEM_Imagotipo-scaled-1.png\",\"width\":2558,\"height\":1138,\"caption\":\"FEGADEM (Federaci\u00f3n Galega de Esclerose M\u00faltiple)\"},\"image\":{\"@id\":\"https:\/\/esclerosismultiplegalicia.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/esclerosemultiplegal?locale=es_ES\",\"https:\/\/x.com\/fegadem\",\"https:\/\/www.instagram.com\/esclerosemultiplegal\/\",\"https:\/\/www.youtube.com\/@fegademfederaciongalegadee3374\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/esclerosismultiplegalicia.org\/#\/schema\/person\/6c5800f07aa0462086b750a2df88cfb4\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"gl-ES\",\"@id\":\"https:\/\/esclerosismultiplegalicia.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/6b01f9a90ea05bdd1053be7f0879b99bae6103fa66164176a65e4bd6fee73fba?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/6b01f9a90ea05bdd1053be7f0879b99bae6103fa66164176a65e4bd6fee73fba?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/prueba.esclerosismultiplegalicia.org\"],\"url\":\"http:\/\/esclerosismultiplegalicia.org\/index.php\/author\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Novo f\u00e1rmaco para a Esclerose M\u00faltiple poder\u00eda revertir o dano neurol\u00f3xico - FEGADEM","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/esclerosismultiplegalicia.org\/index.php\/2024\/09\/05\/novo-farmaco-para-a-esclerose-multiple-poderia-revertir-o-dano-neuroloxico\/","og_locale":"gl_ES","og_type":"article","og_title":"Novo f\u00e1rmaco para a Esclerose M\u00faltiple poder\u00eda revertir o dano neurol\u00f3xico - FEGADEM","og_description":"Novo tratamento poder\u00eda revertir o dano neurol\u00f3xico na EM, abrindo&hellip; Ler m\u00e1is sobre Novo f\u00e1rmaco para a Esclerose M\u00faltiple poder\u00eda revertir o dano neurol\u00f3xico","og_url":"https:\/\/esclerosismultiplegalicia.org\/index.php\/2024\/09\/05\/novo-farmaco-para-a-esclerose-multiple-poderia-revertir-o-dano-neuroloxico\/","og_site_name":"FEGADEM","article_publisher":"https:\/\/www.facebook.com\/esclerosemultiplegal?locale=es_ES","article_published_time":"2024-09-05T13:21:00+00:00","article_modified_time":"2025-09-05T14:09:22+00:00","author":"admin","twitter_card":"summary_large_image","twitter_creator":"@fegadem","twitter_site":"@fegadem","twitter_misc":{"Escrito por":"admin","Tempo de lectura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/esclerosismultiplegalicia.org\/index.php\/2024\/09\/05\/novo-farmaco-para-a-esclerose-multiple-poderia-revertir-o-dano-neuroloxico\/#article","isPartOf":{"@id":"https:\/\/esclerosismultiplegalicia.org\/index.php\/2024\/09\/05\/novo-farmaco-para-a-esclerose-multiple-poderia-revertir-o-dano-neuroloxico\/"},"author":{"name":"admin","@id":"https:\/\/esclerosismultiplegalicia.org\/#\/schema\/person\/6c5800f07aa0462086b750a2df88cfb4"},"headline":"Novo f\u00e1rmaco para a Esclerose M\u00faltiple poder\u00eda revertir o dano neurol\u00f3xico","datePublished":"2024-09-05T13:21:00+00:00","dateModified":"2025-09-05T14:09:22+00:00","mainEntityOfPage":{"@id":"https:\/\/esclerosismultiplegalicia.org\/index.php\/2024\/09\/05\/novo-farmaco-para-a-esclerose-multiple-poderia-revertir-o-dano-neuroloxico\/"},"wordCount":535,"publisher":{"@id":"https:\/\/esclerosismultiplegalicia.org\/#organization"},"keywords":["Investigaci\u00f3n","Tratamentos"],"articleSection":["Novas"],"inLanguage":"gl-ES"},{"@type":"WebPage","@id":"https:\/\/esclerosismultiplegalicia.org\/index.php\/2024\/09\/05\/novo-farmaco-para-a-esclerose-multiple-poderia-revertir-o-dano-neuroloxico\/","url":"https:\/\/esclerosismultiplegalicia.org\/index.php\/2024\/09\/05\/novo-farmaco-para-a-esclerose-multiple-poderia-revertir-o-dano-neuroloxico\/","name":"Novo f\u00e1rmaco para a Esclerose M\u00faltiple poder\u00eda revertir o dano neurol\u00f3xico - FEGADEM","isPartOf":{"@id":"https:\/\/esclerosismultiplegalicia.org\/#website"},"datePublished":"2024-09-05T13:21:00+00:00","dateModified":"2025-09-05T14:09:22+00:00","breadcrumb":{"@id":"https:\/\/esclerosismultiplegalicia.org\/index.php\/2024\/09\/05\/novo-farmaco-para-a-esclerose-multiple-poderia-revertir-o-dano-neuroloxico\/#breadcrumb"},"inLanguage":"gl-ES","potentialAction":[{"@type":"ReadAction","target":["https:\/\/esclerosismultiplegalicia.org\/index.php\/2024\/09\/05\/novo-farmaco-para-a-esclerose-multiple-poderia-revertir-o-dano-neuroloxico\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/esclerosismultiplegalicia.org\/index.php\/2024\/09\/05\/novo-farmaco-para-a-esclerose-multiple-poderia-revertir-o-dano-neuroloxico\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inicio","item":"http:\/\/esclerosismultiplegalicia.org\/"},{"@type":"ListItem","position":2,"name":"Novo f\u00e1rmaco para a Esclerose M\u00faltiple poder\u00eda revertir o dano neurol\u00f3xico"}]},{"@type":"WebSite","@id":"https:\/\/esclerosismultiplegalicia.org\/#website","url":"https:\/\/esclerosismultiplegalicia.org\/","name":"FEGADEM","description":"Traballamos mellorando a calidade de vida das persoas con Esclerose M\u00faltiple en Galicia.","publisher":{"@id":"https:\/\/esclerosismultiplegalicia.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/esclerosismultiplegalicia.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"gl-ES"},{"@type":"Organization","@id":"https:\/\/esclerosismultiplegalicia.org\/#organization","name":"FEGADEM (Federaci\u00f3n Galega de Esclerose M\u00faltiple)","url":"https:\/\/esclerosismultiplegalicia.org\/","logo":{"@type":"ImageObject","inLanguage":"gl-ES","@id":"https:\/\/esclerosismultiplegalicia.org\/#\/schema\/logo\/image\/","url":"http:\/\/esclerosismultiplegalicia.org\/wp-content\/uploads\/2025\/05\/cropped-FEGADEM_Imagotipo-scaled-1.png","contentUrl":"http:\/\/esclerosismultiplegalicia.org\/wp-content\/uploads\/2025\/05\/cropped-FEGADEM_Imagotipo-scaled-1.png","width":2558,"height":1138,"caption":"FEGADEM (Federaci\u00f3n Galega de Esclerose M\u00faltiple)"},"image":{"@id":"https:\/\/esclerosismultiplegalicia.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/esclerosemultiplegal?locale=es_ES","https:\/\/x.com\/fegadem","https:\/\/www.instagram.com\/esclerosemultiplegal\/","https:\/\/www.youtube.com\/@fegademfederaciongalegadee3374"]},{"@type":"Person","@id":"https:\/\/esclerosismultiplegalicia.org\/#\/schema\/person\/6c5800f07aa0462086b750a2df88cfb4","name":"admin","image":{"@type":"ImageObject","inLanguage":"gl-ES","@id":"https:\/\/esclerosismultiplegalicia.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/6b01f9a90ea05bdd1053be7f0879b99bae6103fa66164176a65e4bd6fee73fba?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/6b01f9a90ea05bdd1053be7f0879b99bae6103fa66164176a65e4bd6fee73fba?s=96&d=mm&r=g","caption":"admin"},"sameAs":["https:\/\/prueba.esclerosismultiplegalicia.org"],"url":"http:\/\/esclerosismultiplegalicia.org\/index.php\/author\/admin\/"}]}},"_links":{"self":[{"href":"http:\/\/esclerosismultiplegalicia.org\/index.php\/wp-json\/wp\/v2\/posts\/2734","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/esclerosismultiplegalicia.org\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/esclerosismultiplegalicia.org\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/esclerosismultiplegalicia.org\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/esclerosismultiplegalicia.org\/index.php\/wp-json\/wp\/v2\/comments?post=2734"}],"version-history":[{"count":1,"href":"http:\/\/esclerosismultiplegalicia.org\/index.php\/wp-json\/wp\/v2\/posts\/2734\/revisions"}],"predecessor-version":[{"id":2735,"href":"http:\/\/esclerosismultiplegalicia.org\/index.php\/wp-json\/wp\/v2\/posts\/2734\/revisions\/2735"}],"wp:attachment":[{"href":"http:\/\/esclerosismultiplegalicia.org\/index.php\/wp-json\/wp\/v2\/media?parent=2734"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/esclerosismultiplegalicia.org\/index.php\/wp-json\/wp\/v2\/categories?post=2734"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/esclerosismultiplegalicia.org\/index.php\/wp-json\/wp\/v2\/tags?post=2734"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}